Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML
Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML
Recruiting · NCT07304232 · Registry updated 2025-12-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2025-12-26 | NCT07304232 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 285 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences | Tianjin | China | 8 |
| The First Affiliated Hospital of Harbin Medical University | Harbin | China | 23 |
| The Second Hospital of Hebei Medical University | Shijiazhuang | China | 30 |
| Tianjin Medical University General Hospital | Tianjin | China | 2 |
| Tianjin People's Hospital | Tianjin | China | 1 |